You are here

Publications

Found 466 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Liu J, Guan X, Ma X.  2005.  Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.. J Biol Chem. 280(26):24347-55.
Liu J, Ma X.  2006.  Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1.. J Biol Chem. 281(28):19188-95.
D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G.  1993.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.. J Exp Med. 178(3):1041-8.
Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G.  1996.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.. J Exp Med. 183(1):147-57.
Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X.  2007.  Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1.. Immunity. 27(6):952-64.
Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G.  1997.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.. Methods. 11(1):116-27.
Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, Jimenez V, Ma X.  2005.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.. Curr Immunol Rev. 1(2):119-137.
Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G.  1995.  Interleukin-12 production by human polymorphonuclear leukocytes.. Eur J Immunol. 25(1):1-5.
Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G.  1995.  Interleukin-12 production by human polymorphonuclear leukocytes.. Eur J Immunol. 25(1):1-5.
Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M.  2009.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.. Mucosal Immunol. 2(4):340-50.
Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M.  2009.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.. Mucosal Immunol. 2(4):340-50.
Kim SJun, Gershov D, Ma X, Brot N, Elkon KB.  2002.  I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation.. J Exp Med. 196(5):655-65.
L
Eggink D, Melchers M, Wuhrer M, van Montfort T, Dey AK, Naaijkens BA, David KB, Le Douce V, Deelder AM, Kang K et al..  2010.  Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.. Virology. 401(2):236-47.
Eggink D, Melchers M, Wuhrer M, van Montfort T, Dey AK, Naaijkens BA, David KB, Le Douce V, Deelder AM, Kang K et al..  2010.  Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.. Virology. 401(2):236-47.
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N et al..  2019.  Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.. Nature. 571(7763):72-78.
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N et al..  2019.  Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.. Nature. 571(7763):72-78.
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N et al..  2019.  Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.. Nature. 571(7763):72-78.
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N et al..  2019.  Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.. Nature. 571(7763):72-78.
Burton DR, Hessell AJ, Keele BF, Klasse PJohan, Ketas TA, Moldt B, D Dunlop C, Poignard P, Doyle LA, Cavacini L et al..  2011.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.. Proc Natl Acad Sci U S A. 108(27):11181-6.
Burton DR, Hessell AJ, Keele BF, Klasse PJohan, Ketas TA, Moldt B, D Dunlop C, Poignard P, Doyle LA, Cavacini L et al..  2011.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.. Proc Natl Acad Sci U S A. 108(27):11181-6.
Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JHJ, Sung PA, Jasin M et al..  2012.  Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.. PLoS Genet. 8(7):e1002772.
Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JHJ, Sung PA, Jasin M et al..  2012.  Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.. PLoS Genet. 8(7):e1002772.